Alexandra is a co-founder and investment director at Apollo Health Ventures, the leading biotech company builder and venture capital fund focused on targeting the mechanisms of aging to combat chronic age-related diseases. At Apollo, Alexandra is heading the venture creation program, where she conceptualizes and builds novel biotech and healthtech ventures while also overseeing the pipeline for external investment opportunities. Before joining Apollo, Alexandra worked with The Boston Consulting Group where she specialized in biopharma strategy. Alexandra is a trained pharmacist, and focused on investigating the molecular mechanisms that contribute to cellular aging duringher PhD studies in pharmacology and biomedical sciences at Harvard Medical School.
The opinions expressed in interviews or commentary in articles appearing on this site are those of the subject or subjects and do not necessarily reflect the views of LEAF/Lifespan.io, its directors, officers or employees.